ETON - Eton Pharmaceuticals GAAP EPS of -$0.02 revenue of $7M November, 09 2023 04:14 PM Eton Pharmaceutcials Inc. 2023-11-09 16:14:13 ET Eton Pharmaceuticals press release ( NASDAQ: ETON ): Q3 GAAP EPS of -$0.02. Revenue of $7M (+118.8% Y/Y). For further details see: Eton Pharmaceuticals GAAP EPS of -$0.02, revenue of $7M